INVESTIGATING SAFETY AND PRELIMINARY EFFICACY OF AFM13 PLUS PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA AFTER BRENTUXIMAB VEDOTIN FAILURE
Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 177-178
10.1002/hon.134_2629